END NOTES A1 Racial and ethnic identifiers: Facts and Figures keeps the racial and ethnic terms used in source documents when describing study findings
HIV/AIDS, Alzheimers, Parkinsons disease, asthma, different cancers, cataracts, macular degeneration, open angle glaucoma, diabetes, and many diseases of the liver, kidneys, lungs, and digestive system.18 Research has demonstrated that glutathione deficiency may be a factor in many chronic conditions
Key Takeaways Injectable GHK-Cu: 12mg per injection, once or twice daily Topical GHK-Cu cream/serum: 24% concentration, once or twice daily Cycle length: 812 weeks on, 4 weeks off 100mg vial at 2mg/day = 50 days of use Results start showing at weeks 34, significant at weeks 68 Most popular setup: 100mg vial + 2mL BAC water = 50mg/mL concentration Free calculator: Reconstitution Calculator The standard injectable GHK-Cu dose is 12mg per day, subcutaneously
It is crucial to monitor your bodys response and report any adverse effects to your healthcare provider immediately
When Researchers Would Want a Non-Standard Ratio The 1:1 ratio is the right starting point for most BPC-157+TB-500 combination research, but specific research questions might call for different proportions: Studying angiogenesis-dominant repair models weight BPC-157 more heavily
